Showing 19,541 - 19,560 results of 34,925 for search '(( 50 ((a decrease) OR (greater decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.18s Refine Results
  1. 19541
  2. 19542
  3. 19543
  4. 19544

    <i>Smad6</i> repression in senescence. by Atsushi Kaneda (198186)

    Published 2011
    “…(<i>F</i>) Western blot analysis showing increased level of Smad1/5/8 phosphorylation in RasV12, and decrease in <i>Smad6</i>-introduced RasV12 cells. Numbers under bands of phosphorylated Smad1/5/8 and pan-Smad1 showed densities relative to the band for RasV12 cells (<i>left panel</i>), and the ratio of densities for phosphorylated Smad1/5/8 to pan-Smad1 was decreased to 0.25-fold in <i>Smad6</i>-introduced RasV12 cells (<i>right panel</i>). …”
  5. 19545

    Transcriptomics identifies keratin filaments working downstream of mitochondrial Ca<sup>2+</sup> dynamics to regulate melanogenesis. by Jyoti Tanwar (2230597)

    Published 2024
    “…<b>(E)</b> Venn Diagram representing common differentially regulated genes upon silencing of MCU and MCUb. …”
  6. 19546

    NF-κB and AP-1 are involved in the induction of the antiviral state in THP-1 cells. by Natacha Merindol (3521828)

    Published 2018
    “…Numbers represent the fold decrease in % GFP<sup>+</sup> cells relative to mock-infected cells treated similarly. …”
  7. 19547

    TRIM5α induces an antiviral state following infection with restricted viruses. by Natacha Merindol (3521828)

    Published 2018
    “…The total percentage of GFP<sup>+</sup> cells is shown in bold. <b>(b)</b> Fold decreases in NRC1<sub>GFP</sub> (n = 25) and NRC10<sub>GFP</sub> (n = 17) infectivity in T5KO and control (CAG) Jurkat cells subjected to a first infection with isolates-derived DsRed-vectors. …”
  8. 19548
  9. 19549

    Occupancy of PRC1 and PRC2 at Rest peaks in <i>Wt</i> and <i>Rest</i>−/− mES cells. by Nikolaj Dietrich (181521)

    Published 2012
    “…P-values were calculated by comparing the number of Rest binding sites with 1.5 fold increase or decrease to those expected from a population with similar distribution as the matched control using chi<sup>2</sup>-tests (C) ChIP-seq profiles for the positions marked 1 to 6 in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002494#pgen-1002494-g004" target="_blank">Figure 4B</a> as examples. …”
  10. 19550
  11. 19551

    Impact of Pulsed Dielectrophoretic Supply on the Function of Microorganisms in Membrane Bioreactors by Larbi B.

    Published 2018
    “…A comparison between the continuous and intermittent voltage supply for the 50 V further proved the Joule heating impact on the bacteria viability.…”
    Get full text
    Get full text
  12. 19552

    Inhibition of full-length wild-type capsid polymerization kinetics by two CA binding agents. by Magdeleine Hung (158371)

    Published 2013
    “…The dose response curves of inhibition of polymerization kinetics and the concentration of inhibitor resulting in a half-maximal inhibition (IC<sub>50</sub>) for (<b>B</b>) CAI-4 and (<b>D</b>) BM2. …”
  13. 19553

    Bortezomib inhibits infectious DENV production in primary monocytes. by Milly M. Choy (790882)

    Published 2015
    “…(E) Bortezomib also inhibited 50% of virus production of the attenuated strain of yellow fever virus, YF17D, at a concentration of 0.5 nM. …”
  14. 19554
  15. 19555
  16. 19556
  17. 19557
  18. 19558
  19. 19559

    DataSheet_1_Patient-Reported Outcomes-Guided Adaptive Radiation Therapy for Head and Neck Cancer.docx by Sarah Weppler (10931013)

    Published 2021
    “…Dose-PRO relationships were strongest between delivered pharyngeal constrictor Dmean and patient-reported dysphagia, with MDADI composite scores (mean ± SD) of 25.7 ± 18.9 for patients with Dmean <50 Gy vs. 32.4 ± 17.1 with Dmean ≥50 Gy. Based on logistic regression models, during-treatment dose corrections back to planned values may confer ≥5% decrease in the absolute risk of self-reported physical dysphagia symptoms ≥1 year post-treatment in 1.2% of patients, with a ≥5% decrease in relative risk in 23.3% of patients.…”
  20. 19560

    Practical facility-level approaches to reduce the malaria test positivity rate in Oyo State, Nigeria dataset.csv by Esther Oluwayemisi Ayandipo (18777193)

    Published 2024
    “…A review of the period from January to December 2021 showed a decrease in TPR from 53%-29%, compared to January to December 2022 with TPR decrease from 25%-31%. …”